Ketamine Therapy for
Postpartum Depression

There is a version of new motherhood that everyone talks about. The immediate rush of love. The feeling that everything has clicked into place. And for many mothers, some version of that does happen.

But for roughly 1 in 7 mothers, the experience is different. Instead of connection, there is distance. Instead of joy, there is a flatness — or an anxiety so sharp it cuts through everything. Instead of the bonding you were told would happen naturally, there is a gap between what you expected to feel and what you actually feel.

That gap is not a personal failure. It is postpartum depression.

PPD is driven by a convergence of biological forces: dramatic hormonal shifts after delivery (estrogen and progesterone drop rapidly), severe sleep deprivation during a period of extraordinary physical recovery, and the neurological stress of adapting to an entirely new identity — all at once. The brain is under more pressure than it has ever been, with fewer resources to manage it.

PPD can begin within days of delivery or develop gradually over the first year. It can look like persistent sadness, irritability, difficulty bonding with your baby, intrusive thoughts, withdrawal from people you love, or a sense that you are failing at something everyone else seems to do effortlessly.

You are not failing. Your brain is struggling under conditions that would challenge anyone. And there are treatments that can help — some faster than you might expect.

SSRIs and SNRIs are the most commonly prescribed medications for depression, including postpartum depression. They work by increasing serotonin availability between neurons, and for many people, they are genuinely helpful.

But they have a timeline problem.

Most traditional antidepressants take 4 to 8 weeks to reach full therapeutic effect. For someone navigating treatment-resistant depression that has developed over years, that timeline — while frustrating — is manageable. For a new mother in the first weeks of her baby's life, four to eight weeks is not just inconvenient. It is an eternity.

Those early weeks and months are when bonding happens. When feeding patterns are established. When the foundation of the relationship between mother and child is being built. Every day of severe depression during that window is a day that carries real weight.

There is also the breastfeeding question. While many SSRIs are considered compatible with breastfeeding, the concern is real for mothers who worry about any medication reaching their baby. Some mothers delay treatment entirely because of this concern — which means they suffer longer than they need to.

And then there are the mothers for whom SSRIs simply do not work well enough. The response rates for antidepressants in postpartum depression are similar to general depression: meaningful improvement in roughly 50–60% of patients. For the rest, the medication either partially helps or does not help at all.

This is where the search for faster-acting, differently-targeted treatments becomes not just academic — but urgent.

Ketamine works through a fundamentally different mechanism than traditional antidepressants. Rather than targeting serotonin, it acts on the glutamate system — the brain's primary excitatory neurotransmitter and the one most involved in synaptic plasticity.

By blocking NMDA receptors, ketamine triggers a cascade that increases brain-derived neurotrophic factor (BDNF) and activates the mTOR signaling pathway. These are the biological mechanisms responsible for building and strengthening synaptic connections. In practical terms: ketamine helps the brain restore the wiring that depression has degraded.

Research suggests this is why ketamine can produce effects so quickly. Rather than slowly shifting neurotransmitter levels over weeks, it directly promotes neuroplasticity — the brain's ability to form new connections and adapt. Studies using two-photon microscopy have shown visible new dendritic spine growth within 24 hours of a single dose.

For postpartum depression specifically, this rapid onset is significant. Emerging research suggests that the neuroplasticity window ketamine opens may support not just mood improvement, but the broader cognitive and emotional flexibility that new motherhood demands. You can read more about this mechanism in our article on ketamine and neuroplasticity.

Early clinical studies on ketamine for postpartum depression have shown promising results, with many patients reporting a noticeable shift in mood and energy within hours to days of their first infusion. This is not a permanent fix from a single session — most patients benefit from an initial series of infusions — but the speed of initial response can be meaningful for a mother who is struggling right now.

This is one of the first questions new mothers ask, and it deserves a careful, honest answer.

Ketamine is detectable in breast milk for a period after administration. The current body of research on ketamine and breastfeeding is limited, and there is no large-scale study that definitively establishes safety guidelines. This is an area where the science is still developing.

What we do know: ketamine has a relatively short half-life (approximately 2.5 hours for the initial phase), and many providers recommend a pump-and-dump protocol for 12 to 24 hours after an infusion. This means expressing and discarding breast milk during that window, then resuming normal feeding afterward.

This is a deeply personal decision. Some mothers choose to build a supply of pumped milk before their infusion so their baby's feeding schedule is uninterrupted. Others are formula-feeding and this concern does not apply. And some mothers weigh the severity of their depression against the temporary disruption to breastfeeding and decide that treating the depression is the more urgent priority.

None of these choices is wrong. We will walk through the specifics with you, discuss what the current research shows, and help you make the decision that is right for your family. Your provider will never pressure you in either direction.

We understand that walking through our door may be one of the harder things you do. You may feel guilt about needing help. You may feel uncertain about whether this is the right choice. You may feel like you should be handling this on your own.

You should not have to handle this on your own. And you do not have to.

Marla Peterson, CRNA, founded Music City Ketamine with the belief that people deserve to be treated as whole human beings — not diagnoses. She understands the particular vulnerability of new motherhood and the courage it takes to ask for help during a time when the world expects you to be happy.

Your experience here is designed to feel nothing like a clinical setting. Our treatment suites are private, spa-like, and warm. You will have a weighted blanket, an eye mask, and curated music. Walter and Wilma — our therapy dogs — may be nearby, and many patients find their calm presence grounding.

Marla monitors every infusion personally, calibrating your dose in real time based on how you are responding. Hospital-grade monitoring tracks your vital signs throughout. You are never left alone.

You are welcome to bring your partner or a support person. Many new mothers find it helpful to have someone they trust nearby, especially during a first session. There is space for them in the suite, and they are welcome to stay for the entire infusion.

A typical infusion lasts about 40 minutes, with additional time before and after for settling in and recovery. Most patients are ready to leave within 90 minutes to two hours. You will need someone to drive you home.

We believe cost should not be a barrier to treatment. If you have questions about payment or want to understand what your insurance may cover, call us at (615) 988-4600 and we will walk you through your options.